Bart L Scott (Bart Scott)

Publication Activity (10 Years)

Years Active: 2015-2023
Publications (10 Years): 11

Top Topics

Stem Cell Transplantation

Acute Lymphoblastic Leukemia

Patients Undergoing

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Anna B Halpern, Eduardo Rodríguez-Arbolí, Megan Othus, Kelsey-Leigh A Garcia, Mary-Elizabeth M Percival, Ryan D Cassaday, Vivian G Oehler, Pamela S Becker, Jacob Appelbaum, Janis L Abkowitz, Johnnie J Orozco, Sioban B Keel, Paul C Hendrie, Bart L Scott, Cristina Maria M Ghiuzeli, Elihu Estey, Roland Bruno Walter
Phase 1/2 Study of Sorafenib Added to Cladribine, High-Dose Cytarabine, G-CSF, and Mitoxantrone in Untreated AML. Blood advances (2023)
Roni Tamari, Donal P McLornan, Kwang Woo Ahn, Noel Estrada-Merly, Juan Carlos Carlos Hernández-Boluda, Sergio A Giralt, Jeanne M Palmer, Robert Peter Gale, Zachariah DeFilipp, David Marks, Marjolein W M van der Poel, Leo F Verdonck, Minoo Battiwalla, Miguel A Díaz, Vikas K Gupta, Haris Ali, Mark R Litzow, Hillard M Lazarus, Usama Gergis, Asad Bashey, Jane L Liesveld, Shahrukh K. Hashmi, Jeffrey J Pu, Amer Beitinjaneh, Christopher N Bredeson, David A Rizzieri, Bipin N Savani, Muhammad Bilal Abid, Siddhartha Ganguly, Vaibhav Agrawal, Vera Ulrike Bacher, Baldeep Wirk, Tania Jain, Corey S Cutler, Mahmoud Aljurf, Tamila Kindwall-Keller, Mohamed A Kharfan-Dabaja, Gerhard C Hildebrandt, Attaphol Pawarode, Melhem M Solh, Jean A Yared, Michael R Grunwald, Sunita Nathan, Taiga Nishihori, Sachiko Seo, Bart L Scott, Ryotaro Nakamura, Betul Oran, Tomasz Czerw, Ibrahim Yakoub Agha, Wael Saber
A Simple Prognostic System in Myelofibrosis Patients Undergoing Allogeneic Stem Cell Transplant: A CIBMTR/EBMT analysis. Blood advances (2023)
Stephen T Oh, Ruben A Mesa, Claire N Harrison, Prithviraj Bose, Aaron T Gerds, Vikas K Gupta, Bart L Scott, Jean-Jacques Kiladjian, Alessandro Lucchesi, Tim Kong, Sarah A Buckley, Shanthakumar Tyavanagimatt, Bryan G Harder, Karisse Roman-Torres, Jennifer Smith, Adam R Craig, John O Mascarenhas, Srdan Verstovsek
Pacritinib is a potent ACVR1 inhibitor with significant anemia benefit in patients with myelofibrosis. Blood advances (2023)
Nico Gagelmann, Anita Badbaran, Rachel B Salit, Thomas Schroeder, Carmelo Gurnari, Simona Pagliuca, Victoria Panagiota, Christina Rautenberg, Bruno Cassinat, Felicitas R Thol, Christine Wolschke, Marie Robin, Michael Heuser, Marie-Thérèse Rubio, Jaroslaw P Maciejewski, Hans Christian Reinhardt, Bart L Scott, Nicolaus Kroeger
Impact of TP53 on outcome of patients with myelofibrosis undergoing hematopoietic stem cell transplantation. Blood (2023)
Simone K Feurstein, Amy M Trottier, Noel Estrada-Merly, Matthew J Pozsgai, Kelsey E McNeely, Michael W Drazer, Brian Ruhle, Katharine Sadera, Ashwin L Koppayi, Bart L Scott, Betul Oran, Taiga Nishihori, Vaibhav Agrawal, Ayman Saad, R Coleman Lindsley, Ryotaro Nakamura, Soyoung Kim, Zhen-Huan Hu, Ronald M Sobecks, Stephen R Spellman, Wael Saber, Lucy A Godley
Germline predisposition variants occur in myelodysplastic syndrome patients of all ages. Blood (2022)
Aaron T Gerds, Bart L Scott, Peter Greenberg, Tara L Lin, Daniel A Pollyea, Amit K Verma, Monique Dail, Yuning Feng, Cherie Green, Connie Ma, Bruno C Medeiros, Mark Yan, Kasra Yousefi, William Donnellan
Atezolizumab alone or in combination did not demonstrate a favorable risk-benefit profile in myelodysplastic syndrome. Blood advances 6 (4) (2022)
Srdan Verstovsek, Haifa Kathrin Al-Ali, John O Mascarenhas, Andrew Charles Perkins, Alessandro Maria Maria Vannucchi, Sanjay R Mohan, Bart L Scott, Dariusz Woszczyk, Steffen Koschmieder, Regina García-Delgado, Rejtő László, Jesse S McGreivy, Wayne P Rothbaum, Jean-Jacques Kiladjian
BOREAS: a global, phase III study of the MDM2 inhibitor navtemadlin (KRT-232) in relapsed/refractory myelofibrosis. Future oncology (London, England) (2022)
Nico Gagelmann, Christine Wolschke, Rachel B Salit, Thomas Schroeder, Markus Ditschkowski, Victoria Panagiota, Bruno Cassinat, Felicitas Thol, Anita Badbaran, Marie Robin, Hans Christian Reinhardt, Francis Ayuk, Michael Heuser, Bart L Scott, Nicolaus Kroeger
Reduced intensity hematopoietic stem cell transplantation for accelerated-phase myelofibrosis. Blood advances 6 (4) (2022)
John O Mascarenhas, Rami S Komrokji, Francesca Palandri, Bruno Martino, Dietger Niederwieser, Andreas Reiter, Bart L Scott, Maria R Baer, Ronald Hoffman, Olatoyosi Odenike, Alessandro M Vannucchi, Jacqueline Bussolari, Eugene Zhu, Esther Rose, Laurie Sherman, Souria Dougherty, Libo Sun, Fei Huang, Ying Wan, Faye M Feller, Aleksandra Rizo, Jean-Jacques Kiladjian
Randomized, Single-Blind, Multicenter Phase II Study of Two Doses of Imetelstat in Relapsed or Refractory Myelofibrosis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (26) (2021)
Ryotaro Nakamura, Wael Saber, Michael J Martens, Alyssa Ramirez, Bart L Scott, Betül Oran, Eric Leifer, Roni Tamari, Asmita Mishra, Richard T Maziarz, Joseph P McGuirk, Peter Westervelt, Sumithira Vasu, Mirinal S Patnaik, Rammurti Kamble, Stephen J Forman, Mikkael A Sekeres, Frederick Appelbaum, Adam Mendizabal, Brent R Logan, Mary M Horowitz, Corey S Cutler
Biologic Assignment Trial of Reduced-Intensity Hematopoietic Cell Transplantation Based on Donor Availability in Patients 50-75 Years of Age With Advanced Myelodysplastic Syndrome. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (30) (2021)
Nicolaus Kroeger, Toni Giorgino, Bart L Scott, Markus Ditschkowski, Haefaa Alchalby, Francisco Cervantes, Alessandro Vannucchi, Mario Cazzola, Enrica Morra, Tatjana Zabelina, Margherita Maffioli, Arturo Pereira, Dietrich Beelen, H Joachim Deeg, Francesco Passamonti
Impact of allogeneic stem cell transplantation on survival of patients less than 65 years of age with primary myelofibrosis. Blood 125 (21) (2015)